FAYETTEVILLE, Ark. - AussieJournal -- Lineus Medical is pleased to announce the appointment of Matt Stuckert to its Board of Directors. Stuckert was previously a member of the Lineus Technical Advisory Board.  Stuckert brings over a decade of sales leadership experience in the vascular access space, and has held key roles at Magnolia Medical, Becton Dickinson, CareFusion, Cardinal Health, Enturia, and Venetec.. Throughout his career, he has successfully built and led sales teams, and has driven commercial growth, particularly in the adoption of novel new vascular technologies.

His expertise in sales strategy and business development will be instrumental in guiding Lineus Medical's continued success. With a deep understanding of the vascular access market, Stuckert's knowledge will help support the growth of the company's flagship product, SafeBreak Vascular. Stuckert commented, "I am excited to join Lineus Medical's Board of Directors and contribute to the company's growth. SafeBreak Vascular is a game-changing vascular access device that directly addresses IV complications and improves patient experience, both critical issues in hospitals. I look forward to leveraging my experience to help expand SafeBreak's adoption and support the company's mission of improving IV care."

More on Aussie Journal

• Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
• Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
• This Mother's Day, Give the Gift of Comfort Climate Green Offers Big Discounts on Air Conditioning
• Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
• Cybersecurity is Protecting Your Personal Information and Your Portfolio

Vance Clement, CEO of Lineus Medical said, "Matt Stuckert's extensive experience in vascular access sales and marketing makes him a valuable addition to our Board. His insights will be instrumental as we expand SafeBreak Vascular's presence in hospitals nationwide. We are excited to have him join our board as we continue to revolutionize what vascular access care looks like."

SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications¹. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.¹

More on Aussie Journal

• L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
• Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
• Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs
• The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
• $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD

About Lineus Medical

Lineus Medical is the developer of break-away technology proven to reduce IV restarts and complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

References:
1. Data on File